Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2008
02/14/2008CA2659967A1 Quinazoline derivatives
02/14/2008CA2659154A1 An aminoisoquinoline thrombin inhibitor with improved bioavailability
02/13/2008EP1887003A1 3-[4-heterocyclyl -1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
02/13/2008EP1887002A1 Carboxamide compound and use thereof
02/13/2008EP1886996A1 1H-Quinolin-4-one compounds, with affinity for the GABA receptor, processes, uses and compositions
02/13/2008EP1886994A1 Cyclic amine compounds as CCR5 antagonists
02/13/2008EP1885713A1 1, 2, 4 -triazole derivatives as vasopressin antagonists
02/13/2008EP1885712A1 New 2-pyridinylcycloalkylcarboxamide derivatives as fungicides.
02/13/2008EP1885711A1 Esomeprazole strontium salt, process for its preparation and pharmaceutical compositions containing same
02/13/2008EP1885710A1 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
02/13/2008EP1885695A2 Novel indoline compounds
02/13/2008EP1536796B1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
02/13/2008EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
02/13/2008EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists
02/13/2008EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
02/13/2008EP1335908B1 Peroxisome proliferator activated receptor alpha agonists
02/13/2008CN101124222A Tetrahydroquinoline analogues as muscarinic agonists
02/13/2008CN101124219A Novel farnesyl protein transferase inhibitors as antitumor agents
02/13/2008CN101124218A Unsymmetrical diazo compounds, compositions comprising same, dyeing method and device comprising said compositions
02/13/2008CN101124217A CGRP receptor antagonists
02/13/2008CN101124216A Heterocyclic MCHr1 antagonists and their use in therapy
02/13/2008CN101124215A Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders
02/13/2008CN101124208A Novel heteroaryl acetamide
02/13/2008CN101124203A Chemical compounds
02/13/2008CN101124201A Parp抑制剂 Parp inhibitors
02/13/2008CN101123964A G-protein coupled receptor(GPR116) agonists and use thereof for treating obesity and diabetes
02/13/2008CN101123962A 可诱导一氧化氮合成酶二聚化的抑制剂 Inducible nitric oxide synthase dimerization inhibitor
02/13/2008CN101121711A Pyrazolcarbazone derivatives and application thereof
02/13/2008CN101121710A Method for synthesizing chemiluminescent substance acridinum ester DMAE.NHS
02/13/2008CN101121695A Method for preparing nitrogen-containing onium salt compounds
02/13/2008CN101121692A Synthesis method for alpha-carbonylamide compound
02/13/2008CN100368404C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
02/12/2008US7329898 Transition metal complex and light-emitting device
02/12/2008US7329765 Benzothiophene compounds having antiinfective activity
02/12/2008US7329762 Prodrugs of mitotic kinesin inhibitors
02/12/2008US7329757 Chloroazinium compounds: 2-chloro-5-methyl-1-(3-trifluoromethyl-phenyl)-pyridinium chloride; intermediates for preparting iminoazine herbicides: N-cyclopropyl-5-methyl-1-(3-trifluoromethylphenyl)-2(1H)-pyridineimine
02/12/2008US7329752 4-(tetrahydrofuran-2-carbonyl)piperazine-1-carboxylic acid 3-{(1S,3R,5R)-3-[(3-isopropyl-2-oxo-2,3-dihydro-benzoimidazole-1-carbonyl)amino]-8-aza-[3.2.1]oct-8-yl}propyl ester; disorder of reduced motility of the gastrointestinal tract
02/12/2008US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound
02/12/2008US7329680 Heterocycle substituted carboxylic acids
02/12/2008US7329678 Benzimidazolyl-pyridine derivatives; Serum and Glucocorticoid-Regulated Kinase 1 inhibitors; 3-(1H-benzimidazol-2-yl)-5-phenylpyridin-2-amine; regulation of electrolyte balance in renal and cardiovascular disease, antiproliferative agents, rheumatoid arthritis, psoriasis, septic shock, bone loss
02/12/2008US7329675 Substituted azabicyclic compounds
02/12/2008US7329673 selective agonists of (MC-4R); obesity, diabetes, male and female sexual dysfunction, insulin resistance, osteoartritis; long duration of action, side effects reduction; stereoisomers
02/12/2008US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
02/12/2008US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
02/12/2008US7329669 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
02/12/2008US7329665 Quinazolinone derivative
02/12/2008US7329664 Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
02/12/2008US7329661 N-phenyl-3-pyrimidine-amine derivatives
02/12/2008US7329660 Phthalazine derivatives for treating inflammatory diseases
02/12/2008US7329659 Substituted-1-phthalazinamines as vr-1 antagonists
02/12/2008US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors
02/12/2008US7329656 Arylthiobenzylpiperidine derivatives
02/12/2008US7329655 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent
02/12/2008CA2385996C Anticancer agents
02/12/2008CA2374737C Novel process for synthesis of heteroaryl-substituted urea compounds
02/12/2008CA2315261C Oral pharmaceutical extended release dosage form
02/12/2008CA2295817C Method for producing pyridine compound
02/12/2008CA2290992C (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
02/12/2008CA2258701C Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
02/12/2008CA2208672C Immunotherapeutic imides/amides and their use for reducing levels of tnf.alpha.
02/07/2008WO2008016973A1 2,4-diaminoquinazolines for spinal muscular atrophy
02/07/2008WO2008016913A1 Biologically potent analogues of the dmt-tic pharmacophore and methods of use
02/07/2008WO2008016676A2 Certain chemical entities, compositions, and methods
02/07/2008WO2008016002A1 AMYLOID β PRODUCTION REGULATOR CONTAINING PROTON PUMP INHIBITOR
02/07/2008WO2008015517A2 Ep2 agonists
02/07/2008WO2008015335A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
02/07/2008WO2008014822A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
02/07/2008WO2008014602A1 Quinoline derivatives
02/07/2008WO2007146719A3 2-aminocarbonylphenylamino-2-phenylacetamides as factor viia inhibitors useful as anticoagulants
02/07/2008WO2007146550A3 Alkene piperidine derivatives as antiviral agents
02/07/2008WO2007136300A3 Substituted indoles and a method for the production and use thereof
02/07/2008WO2007117778A3 Quinolones useful as inducible nitric oxide synthase inhibitors
02/07/2008WO2007098826A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
02/07/2008WO2007070506B1 Diaza heterocyclic sulfonamide derivatives and their uses
02/07/2008WO2007035722B1 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
02/07/2008WO2006105304A8 Phenyl and pyridyl lta4h modulators
02/07/2008US20080033179 Exhibit performance properties suited to high-speed optical recording applications; industrial scale; cyanine dyes; indole dyes; cationic dyes; low heat decomposition temperatures
02/07/2008US20080033177 Process for the preparation of substituted-1,2,3,4-tetrahydroisoquinoline derivatives
02/07/2008US20080033175 Process for preparation of 4-amino-3-quinolinecarbonitriles
02/07/2008US20080033171 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
02/07/2008US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders
02/07/2008US20080033002 Modulators of muscarinic receptors
02/07/2008US20080032997 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer
02/07/2008US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative
02/07/2008US20080032992 New Pyridine Analogues V
02/07/2008US20080032990 Inhibitors of advanced glycation end products
02/07/2008US20080032986 Benzyl amines, a process for their production and their use as anti-inflammatory agents
02/07/2008US20080032980 1-Carbonyl-3,5-diphenyl-4,5-dihydro-1H-pyrazoles such as 1-acetyl-4-(1-{[3-(2,5-difluorophenyl)-5-methyl-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl]carbonyl}propyl)piperazine trifluoroacetate that are useful for treating cancer
02/07/2008US20080032979 Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors
02/07/2008US20080032977 Alkyne-substituted pyridone compounds and methods of use
02/07/2008US20080032976 Histamine 3 receptor antagonists and/or inverse agonists; for obesity, metabolic syndrome (syndrome X), and other eating disorders; (4-cyclopentyl-piperazin-1-yl)-[3-(1-isopropyl-piperidin -4-yl)-l H-indol-6-yl]-methanone
02/07/2008US20080032975 Substituted Fused Pyrroleoximes and Fused Pyrazoleoximes
02/07/2008US20080032974 Compounds and therapeutical use thereof
02/07/2008US20080032968 New compounds
02/07/2008US20080032967 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase
02/07/2008CA2659696A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
02/07/2008CA2659376A1 2,4-diaminoquinazolines for spinal muscular atrophy
02/07/2008CA2658799A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
02/07/2008CA2658793A1 Quinoline derivatives
02/07/2008CA2658479A1 Novel hiv reverse transcriptase inhibitors